New NJACTS Publication

Please read Dr. Dave’s article in Circulation titled, “Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy.” Atherosclerotic cardiovascular disease and...